Our findings suggest a more aggressive nature of EO-CRC compared to LO-CRC, potentially explained by the higher frequency of the mucinous histologic subtype, poor tumor differentiation, increased expression of pro-oncogenic factors such as HER2, and reduced expression of tumor suppressor factors such as CDX2. This evidence concerns the gene ERBB2 and neoplasm.